Anjum F, Shakoori A R
Department of Pharmacology, University of Cambridge, England.
J Environ Pathol Toxicol Oncol. 1994;13(2):125-32.
Hepatotoxic effects of inorganic mercury with and without pretreatment of phenobarbitone and promethazine have been described in experiments on domesticated rabbits. The total body weight and the relative liver weight decreased after mercury treatment under all experimental conditions. After phenobarbitone (PB) treatment, the serum glutamate oxaloacetate transaminase (GOT), glutamate pyruvate transaminase (GPT), isocitrate dehydrogenase (ICDH), and lactate dehydrogenase (LDH) activities decreased to 31%, 77%, 20%, and 27%, respectively, whereas the serum alkaline phosphatase (AP) activity increased 54%. After promethazine (PM) treatment, however, the serum GPT activity was inhibited 73%, whereas the serum LDH activity increased 53%. Both hepatic GPT and AP activities decreased after PB (41% and 46%, respectively) and after PM (50% and 52%, respectively) treatments, while the activities of LDH and ICDH increased (after PB: 924% and 108%, respectively; after PM: 147% and 40%, respectively). After mercuric chloride (HgCl2) treatment, the serum GOT, GPT, LDH, and ICDH activities decreased 69%, 83%, 11%, and 48%, respectively. The hepatic GOT, LDH, and AP activities increased 56%, 129%, and 51%, respectively. The administration of HgCl2 in PB-pretreated animals was associated with a decrease in the activities of serum GOT and AP (57% and 69%, respectively), while the ICDH activity increased 27%. The hepatic GOT, GPT, and AP increased 58%, 135%, and 77%, respectively, after mercury treatment, whereas LDH and ICDH were inhibited 78% and 29%.(ABSTRACT TRUNCATED AT 250 WORDS)
在家养兔子身上进行的实验描述了无机汞在有或没有苯巴比妥和异丙嗪预处理情况下的肝毒性作用。在所有实验条件下,汞处理后动物的总体重和相对肝脏重量均下降。苯巴比妥(PB)处理后,血清谷氨酸草酰乙酸转氨酶(GOT)、谷氨酸丙酮酸转氨酶(GPT)、异柠檬酸脱氢酶(ICDH)和乳酸脱氢酶(LDH)活性分别降至31%、77%、20%和27%,而血清碱性磷酸酶(AP)活性增加54%。然而,异丙嗪(PM)处理后,血清GPT活性被抑制73%,而血清LDH活性增加53%。PB(分别为41%和46%)和PM(分别为50%和52%)处理后,肝脏GPT和AP活性均下降,而LDH和ICDH活性增加(PB处理后分别为924%和108%;PM处理后分别为147%和40%)。氯化汞(HgCl2)处理后,血清GOT、GPT、LDH和ICDH活性分别下降69%、83%、11%和48%。肝脏GOT、LDH和AP活性分别增加56%、129%和51%。在PB预处理的动物中给予HgCl2与血清GOT和AP活性下降(分别为57%和69%)相关,而ICDH活性增加27%。汞处理后,肝脏GOT、GPT和AP分别增加58%、135%和77%,而LDH和ICDH被抑制78%和29%。(摘要截选至250字)